Journal
CLINICAL AND VACCINE IMMUNOLOGY
Volume 21, Issue 2, Pages 133-142Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00620-13
Keywords
-
Categories
Funding
- Hospitals and Homes of St Giles Leprosy Fund
- Gordon Smith Traveling Scholarship
- University of London Central Research Fund
- Bill and Melinda Gates-Gates Grand Challenge [GC6-74]
- EU FP7-NEWTBVAC consortia
- Bill and Melinda Gates Foundation [GC6-74]
Ask authors/readers for more resources
A positive gamma interferon (IFN-gamma) response to Mycobacterium tuberculosis early secretory antigenic target-6 (ESAT-6)/culture filtrate protein-10 (CFP-10) has been taken to indicate latent tuberculosis (TB) infection, but it may also be due to exposure to environmental nontuberculous mycobacteria in which ESAT-6 homologues are present. We assessed the immune responses to M. tuberculosis ESAT-6 and cross-reactive responses to ESAT-6 homologues of Mycobacterium avium and Mycobacterium kansasii. Archived culture supernatant samples from children at 3 years post-BCG vaccination were tested for cytokine/chemokine responses to M. tuberculosis antigens. Furthermore, the IFN-gamma responses to M. tuberculosis antigens were followed up for 40 children at 8 years post-BCG vaccination, and 15 TB patients were recruited as a control group for the M. tuberculosis ESAT-6 response in Malawi. IFN-gamma enzyme-linked immunosorbent assays (ELISAs) on supernatants from diluted whole-blood assays, IFN-gamma enzyme-linked immunosorbent spot (ELISpot) assays, QuantiFERON TB Gold-In Tube tests, and multiplex bead assays were performed. More than 45% of the responders to M. tuberculosis ESAT-6 showed IFN-gamma responses to M. avium and M. kansasii ESAT-6. In response to M. tuberculosis ESAT-6/CFP-10, interleukin 5 (IL-5), IL-9, IL-13, and IL-17 differentiated the stronger IFN-gamma responders to M. tuberculosis ESAT-6 from those who preferentially responded to M. kansasii and M. avium ESAT-6. A cytokine/chemokine signature of IL-5, IL-9, IL-13, and IL-17 was identified as a putative immunological biosignature to differentiate latent TB infection from exposure to M. avium and M. kansasii in Malawian children, indicating that this signature might be particularly informative in areas where both TB and exposure to environmental nontuberculous mycobacteria are endemic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available